{"id":2063,"date":"2025-08-28T13:30:42","date_gmt":"2025-08-28T13:30:42","guid":{"rendered":"http:\/\/www.xinetica.com\/?p=2063"},"modified":"2025-08-28T16:16:50","modified_gmt":"2025-08-28T16:16:50","slug":"accelerants-net-income-soars-242-to-13-1m-in-q225","status":"publish","type":"post","link":"http:\/\/www.xinetica.com\/index.php\/2025\/08\/28\/accelerants-net-income-soars-242-to-13-1m-in-q225\/","title":{"rendered":"Accelerant\u2019s net income soars 242% to $13.1m in Q2\u201925"},"content":{"rendered":"

Accelerant Holdings has reported a net income of $13.1 million for the second quarter of 2025, marking a 242.4% increase from a net loss of $9.2 million in the same period a year earlier.<\/p>\n

\"AccelerantTotal revenues for the quarter reached $219.1 million, up from $130.1 million in Q2\u201924. This included net earned premiums of $70.6 million and net investment income of $12.8 million, compared with $52.2 million and $8.7 million, respectively.<\/p>\n

Total expenses stood at $198.8 million, an increase from $134.4 million.<\/p>\n

In Q2\u201925, Accelerant had 248 Members, up from 186, with the number of MGA operations members increasing to 47 from 44.<\/p>\n

For the first half of 2025, the company posted a net income of $20.9 million, a notable improvement from a net loss of $7.1 million in H1\u201924.<\/p>\n

\n
\n

\"Register<\/a><!–\"Download<\/a>–><\/p>\n<\/div>\n<\/div>\n

Total revenues were $397.1 million, up from $258.2 million. Net earned premiums rose to $133.6 million from $96.2 million, while net investment income increased to $25 million from $16.6 million.<\/p>\n

Total expenses in H1\u201925 amounted to $359.3 million, up from $250.5 million.<\/p>\n

In July 2025, Accelerant also announced the pricing of its upsized initial public offering<\/a>, expecting to raise $426 million for the firm.<\/p>\n

Jeff Radke, Co-Founder and CEO, said, \u201cAccelerant\u2019s first quarter reporting as a public company was one of the strongest in our history \u2014 more Members wrote more business for more risk capital partners than ever before.<\/p>\n

\u201cWe believe our initial public offering validated the durability of our platform and equipped us with resources to extend industry-leading growth as we build the world\u2019s preeminent two-sided specialty insurance risk exchange. Over the last 12 months, Accelerant generated $3.8 billion of Exchange Written Premium, including $1.1 billion in the second quarter alone \u2014 a 42% year-over-year increase.<\/p>\n

\u201cOur growth algorithm is straightforward: add more high-quality Members, expand specialty products for more small and mid-sized businesses, and attract more capital from risk partners.<\/p>\n

\u201cIf we continue to do that, we believe the rest will take care of itself. Our goal is clear: to be the rails on which specialty insurance runs.\u201d<\/p>\n

The post Accelerant\u2019s net income soars 242% to $13.1m in Q2\u201925<\/a> appeared first on ReinsuranceNe.ws<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

Accelerant Holdings has reported a net income of $13.1 million for the second quarter of 2025, marking a 242.4% increase […]<\/p>\n","protected":false},"author":1,"featured_media":2065,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[14],"tags":[],"_links":{"self":[{"href":"http:\/\/www.xinetica.com\/index.php\/wp-json\/wp\/v2\/posts\/2063"}],"collection":[{"href":"http:\/\/www.xinetica.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.xinetica.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.xinetica.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.xinetica.com\/index.php\/wp-json\/wp\/v2\/comments?post=2063"}],"version-history":[{"count":3,"href":"http:\/\/www.xinetica.com\/index.php\/wp-json\/wp\/v2\/posts\/2063\/revisions"}],"predecessor-version":[{"id":2067,"href":"http:\/\/www.xinetica.com\/index.php\/wp-json\/wp\/v2\/posts\/2063\/revisions\/2067"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.xinetica.com\/index.php\/wp-json\/wp\/v2\/media\/2065"}],"wp:attachment":[{"href":"http:\/\/www.xinetica.com\/index.php\/wp-json\/wp\/v2\/media?parent=2063"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.xinetica.com\/index.php\/wp-json\/wp\/v2\/categories?post=2063"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.xinetica.com\/index.php\/wp-json\/wp\/v2\/tags?post=2063"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}